重组人脑利钠肽治疗难治性心力衰竭的临床观察被引量：1

下载PDF

导出

摘要目的观察重组人脑利钠肽(rh-BNP)治疗难治性心力衰竭的疗效。方法将难治性心力衰竭患者100例随机分为观察组和对照组各50例,对照组予常规治疗,观察组在对照组基础上加用rh-BNP治疗。治疗后对比观察2组患者的临床疗效,测定2组患者治疗前后的血浆B型脑钠肽(BNP)及左心室射血分数(LVEF)水平。结果观察组总有效率为92.0%明显高于对照组的76.0%(P<0.05);治疗后,2组BNP水平均降低,LVEF水平均升高,且观察组波动幅度大于对照组,差异均有统计学意义(P<0.05)。结论运用rh-BNP治疗难治性心力衰竭,可明显减轻心力衰竭的症状,改善患者的心功能,疗效确切。

作者邓荣花闫文珍

机构地区大同现代医院山西省大同市第五人民医院

出处《临床合理用药杂志》 2016年第34期39-40,共2页 Chinese Journal of Clinical Rational Drug Use

关键词脑利钠肽难治性心力衰竭心功能

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1黄颂波.重组人脑利钠肽对顽固性心力衰竭患者NT-proBNP、LVDD、LVEF的影响[J].中国实用医药,2015,10(25):81-82. 被引量：1
2梁海青,郭牧,张云强,贾志,宋昱.重组人脑利钠肽联合硝普钠治疗急性失代偿性心力衰竭的疗效评价[J].中华老年心脑血管病杂志,2015,17(8):801-804. 被引量：60
3张俊岭,牟丽娜,陆芳,吕学新,姚晓斐,郑群.重组人脑利钠肽、多巴胺、呋塞米合用治疗心肾综合征的临床研究[J].河北医药,2015,37(9):1304-1307. 被引量：18
4余淑华.新活素治疗急、慢性及顽固性心力衰竭效果探讨[J].中国实用医药,2014,9(34):129-130. 被引量：4
5汪凛,陈礼学,夏旭辉,万书平.重组人脑利钠肽改善慢性心力衰竭利尿剂抵抗的作用及机制研究[J].疑难病杂志,2015,14(12):1211-1214. 被引量：23
6师东武,弓清梅,栗保平.新活素治疗难治性心力衰竭临床疗效观察[J].中西医结合心脑血管病杂志,2014,12(3):277-278. 被引量：11
7杨爱民,刘春萍.新活素治疗老年难治性心力衰竭临床观察[J].中国现代药物应用,2013,7(3):69-70. 被引量：18

二级参考文献56

1张强.治疗急性失代偿性心力衰竭的新药——冻干重组人脑利钠肽[J].中国药房,2007,18(16):1264-1265. 被引量：10
2WeherM, Hamn C. Role at Btype natriuretie peptide and NT-pro in ehinieal routine. Heat,2006,92(6) :843-849.
3Zhang J,Fu X,Jia X,et al.Btype natriuretic peptide for prevention of contrast induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention[J].Acta Radiol,2010,51(6):641-648.
4Caixeta A,Mehran R.Evidencebased management of patients undergoing PCI:Contrast-induced acute kidney injury[J].Catheter Cardiovasc Interv,2010,75(Suppl 1):s1520.
5Dickstein K,CohenSolal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008[J].Eur Heart J,2008,29(19):23882442.
6Kawakami R,Saito Y,Kishimoto I,et al.Over expression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase9 expression after acute myocardial infarction[J].Circulation,2004,110(21):3306-3312.
7Wayne L,John CK.Role for precursor proB type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide[J].Clinica Chimica Acta,2009,406:119123.
8Abraham WT,Cheng ML,Smoluk G.clinical and hemodynamic effects of nesiritide(B-type natriuretic peptide)inpatients with decompensated heart failure receiving beta blockers[J].Congest Heart Fail,2005,11:5964.
9Strain WD.The use of recombinant human B-type natriutetic peptide (nesiritide) in the management of acute deeompensated heart failure[J].Int J Clin Pract,2004,58(11):10811087.
10Sevimli S, Aksakal E, Tanboga IH, et al. Percutaneous Valve- in-Valve Transcatheter Tricuspid Valve Replacement With Simultaneous Paravalvular Leak Closure in a Patient With R：fractory Right Heart Failure.JACC Cardiovasc Interv, 2014, 7(7): e79-e80.